Your browser doesn't support javascript.
loading
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells.
Martins, Christina; Silva, Mariana; Rasbach, Erik; Singh, Praveen; Itoh, Yuta; Williams, Jason B; Statham, Edith; Meurer, Anna; Martinez, Daniela V; Brandenburg, Anne; Heppt, Markus V; Barthel, Steven R; Schatton, Tobias.
Afiliação
  • Martins C; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Silva M; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Rasbach E; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Singh P; Department of Surgery, University Hospital Mannheim, Heidelberg University, 68167, Mannheim, Germany.
  • Itoh Y; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Williams JB; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Statham E; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Meurer A; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Martinez DV; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Brandenburg A; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Heppt MV; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
  • Barthel SR; Department of Dermatology and Allergology, University Hospital Bonn, 53127, Bonn, Germany.
  • Schatton T; Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, HIM Building, Suite 671, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
Sci Rep ; 12(1): 12491, 2022 07 21.
Article em En | MEDLINE | ID: mdl-35864188

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Antineoplásicos Imunológicos Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Antineoplásicos Imunológicos Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article